Glioma-initiating cells: A predominant role in microglia/macrophages tropism to glioma

Journal of Neuroimmunology

Volumn 232, Issue 1-2, 2011, Pages 75-82

  Yi, Liang ^a   Xiao, Hualiang ^a   Xu, Minhui ^b   Ye, Xianzong ^a   Hu, Jun ^a   Li, Fei ^a   Li, Mei ^a   Luo, Chunxia ^a   Yu, Shicang ^a   Bian, Xiuwu ^a   Feng, Hua ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Brain macrophages; Cancer stem cell; Gliomas; Microglia

Indexed keywords

CD133 ANTIGEN; CD68 ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTOMA; CELL INFILTRATION; CHEMOTAXIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MICROGLIA; MOUSE; NEUROTROPISM; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TUMOR ASSOCIATED LEUKOCYTE;

ANIMALS; BRAIN NEOPLASMS; CHEMOTAXIS, LEUKOCYTE; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MACROPHAGES; MICE; MICE, INBRED C57BL; MICROGLIA; NEOPLASM TRANSPLANTATION; NEOPLASTIC STEM CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 79952250124     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2010.10.011     Document Type: Article

References (40)

1. Badie B., Bartley B., Schartner J. Differential expression of MHC class II and B7 costimulatory molecules by microglia in rodent gliomas. J. Neuroimmunol. 2002, 133:39-45.
2. Bao S., Wu Q., McLendon R.E., Hao Y., Shi Q., Hjelmeland A.B., Dewhirst M.W., Bigner D.D., Rich J.N. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006, 444:756-760.
3. Bao S., Wu Q., Sathornsumetee S., Hao Y., Li Z., Hjelmeland A.B., Shi Q., McLendon R.E., Bigner D.D., Rich J.N. Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res. 2006, 66:7843-7848.
4. Battista D., Ferrari C.C., Gage F.H., Pitossi F.J. Neurogenic niche modulation by activated microglia: transforming growth factor beta increases neurogenesis in the adult dentate gyrus. Eur. J. Neurosci. 2006, 23:83-93.
5. Calabrese C., Poppleton H., Kocak M., Hogg T.L., Fuller C., Hamner B., Oh E.Y., Gaber M.W., Finklestein D., Allen M., Frank A., Bayazitov I.T., Zakharenko S.S., Gajjar A., Davidoff A., Gilbertson R.J. A perivascular niche for brain tumor stem cells. Cancer Cell 2007, 11:69-82.
6. Carraway R.E., Plona A.M. Involvement of neurotensin in cancer growth: evidence, mechanisms and development of diagnostic tools. Peptides 2006, 27:2445-2460.
7. Dey M., Ulasov I.V., Lesniak M.S. Virotherapy against malignant glioma stem cells. Cancer Lett. 2010, 289:1-10.
8. Forstreuter F., Lucius R., Mentlein R. Vascular endothelial growth factor induces chemotaxis and proliferation of microglial cells. J. Neuroimmunol. 2002, 132:93-98.
9. Ginestier C., Liu S., Diebel M.E., Korkaya H., Luo M., Brown M., Wicinski J., Cabaud O., Charafe-Jauffret E., Birnbaum D., Guan J.L., Dontu G., Wicha M.S. CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts. J. Clin. Invest. 2010, 120:485-497.
10. Graeber M.B., Scheithauer B.W., Kreutzberg G.W. Microglia in brain tumors. Glia 2002, 40:252-259.
11. Han H.S., Suk K. The function and integrity of the neurovascular unit rests upon the integration of the vascular and inflammatory cell systems. Curr. Neurovasc. Res. 2005, 2:409-423.
12. Held-Feindt J., Hattermann K., Muerkoster S.S., Wedderkopp H., Knerlich-Lukoschus F., Ungefroren H., Mehdorn H.M., Mentlein R. CX3CR1 promotes recruitment of human glioma-infiltrating microglia/macrophages (GIMs). Exp. Cell Res. 2010, 316:1553-1566.
13. Hong T.M., Teng L.J., Shun C.T., Peng M.C., Tsai J.C. Induced interleukin-8 expression in gliomas by tumor-associated macrophages. J. Neurooncol. 2009, 93:289-301.
14. Imai Y., Kohsaka S. Intracellular signaling in M-CSF-induced microglia activation: role of Iba1. Glia 2002, 40:164-174.
15. Johnson B., Osada T., Clay T., Lyerly H., Morse M. Physiology and therapeutics of vascular endothelial growth factor in tumor immunosuppression. Curr. Mol. Med. 2009, 9:702-707.
16. Kerber M., Reiss Y., Wickersheim A., Jugold M., Kiessling F., Heil M., Tchaikovski V., Waltenberger J., Shibuya M., Plate K.H., Machein M.R. Flt-1 signaling in macrophages promotes glioma growth in vivo. Cancer Res. 2008, 68:7342-7351.
17. Lewis C.E., Pollard J.W. Distinct role of macrophages in different tumor microenvironments. Cancer Res. 2006, 66:605-612.
18. Mantovani A., Allavena P., Sica A., Balkwill F. Cancer-related inflammation. Nature 2008, 454:436-444.
19. Martin S., Vincent J.P., Mazella J. Involvement of the neurotensin receptor-3 in the neurotensin-induced migration of human microglia. J. Neurosci. 2003, 23:1198-1205.
20. Martin S., Dicou E., Vincent J.P., Mazella J. Neurotensin and the neurotensin receptor-3 in microglial cells. J. Neurosci. Res. 2005, 81:322-326.
21. McCord A.M., Jamal M., Williams E.S., Camphausen K., Tofilon P.J. CD133+ glioblastoma stem-like cells are radiosensitive with a defective DNA damage response compared with established cell lines. Clin. Cancer Res. 2009, 15:5145-5153.
22. Nakanishi M., Niidome T., Matsuda S., Akaike A., Kihara T., Sugimoto H. Microglia-derived interleukin-6 and leukaemia inhibitory factor promote astrocytic differentiation of neural stem/progenitor cells. Eur. J. Neurosci. 2007, 25:649-658.
23. Nakano Y., Kuroda E., Kito T., Uematsu S., Akira S., Yokota A., Nishizawa S., Yamashita U. Induction of prostaglandin E2 synthesis and microsomal prostaglandin E synthase-1 expression in murine microglia by glioma-derived soluble factors. Laboratory investigation. J. Neurosurg. 2008, 108:311-319.
24. Nielsen H.M., Veerhuis R., Holmqvist B., Janciauskiene S. Binding and uptake of A beta1-42 by primary human astrocytes in vitro. Glia 2009, 57:978-988.
25. Okada M., Saio M., Kito Y., Ohe N., Yano H., Yoshimura S., Iwama T., Takami T. Tumor-associated macrophage/microglia infiltration in human gliomas is correlated with MCP-3, but not MCP-1. Int. J. Oncol. 2009, 34:1621-1627.
26. Pallini R., Ricci-Vitiani L., Banna G.L., Signore M., Lombardi D., Todaro M., Stassi G., Martini M., Maira G., Larocca L.M., De Maria R. Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme. Clin. Cancer Res. 2008, 14:8205-8212.
27. Platten M., Kretz A., Naumann U., Aulwurm S., Egashira K., Isenmann S., Weller M. Monocyte chemoattractant protein-1 increases microglial infiltration and aggressiveness of gliomas. Ann. Neurol. 2003, 54:388-392.
28. Pull S.L., Doherty J.M., Mills J.C., Gordon J.I., Stappenbeck T.S. Activated macrophages are an adaptive element of the colonic epithelial progenitor niche necessary for regenerative responses to injury. Proc. Natl Acad. Sci. USA 2005, 102:99-104.
29. Sottoriva A., Verhoeff J.J., Borovski T., McWeeney S.K., Naumov L., Medema J.P., Sloot P.M., Vermeulen L. Cancer stem cell tumor model reveals invasive morphology and increased phenotypical heterogeneity. Cancer Res. 2010, 70:46-56.
30. Stiles C.D., Rowitch D.H. Glioma stem cells: a midterm exam. Neuron 2008, 58:832-846.
31. Veeravagu A., Bababeygy S.R., Kalani M.Y., Hou L.C., Tse V. The cancer stem cell-vascular niche complex in brain tumor formation. Stem Cells Dev. 2008, 17:859-867.
32. Watters J.J., Schartner J.M., Badie B. Microglia function in brain tumors. J. Neurosci. Res. 2005, 81:447-455.
33. Wei J., Barr J., Kong L.Y., Wang Y., Wu A., Sharma A.K., Gumin J., Henry V., Colman H., Sawaya R., Lang F.F., Heimberger A.B. Glioma-associated cancer-initiating cells induce immunosuppression. Clin. Cancer Res. 2010, 16:461-473.
34. Wesolowska A., Kwiatkowska A., Slomnicki L., Dembinski M., Master A., Sliwa M., Franciszkiewicz K., Chouaib S., Kaminska B. Microglia-derived TGF-beta as an important regulator of glioblastoma invasion-an inhibition of TGF-beta-dependent effects by shRNA against human TGF-beta type II receptor. Oncogene 2008, 27:918-930.
35. Yao X.H., Ping Y.F., Chen J.H., Xu C.P., Chen D.L., Zhang R., Wang J.M., Bian X.W. Glioblastoma stem cells produce vascular endothelial growth factor by activation of a G-protein coupled formylpeptide receptor FPR. J. Pathol. 2008, 215:369-376.
36. Yi L., Zhou Z.H., Ping Y.F., Chen J.H., Yao X.H., Feng H., Lu J.Y., Wang J.M., Bian X.W. Isolation and characterization of stem cell-like precursor cells from primary human anaplastic oligoastrocytoma. Mod. Pathol. 2007, 20:1061-1068.
37. Yu S.C., Bian X.W. Enrichment of cancer stem cells based on heterogeneity of invasiveness. Stem Cell Rev. 2009, 5:66-71.
38. Yu S.C., Ping Y.F., Yi L., Zhou Z.H., Chen J.H., Yao X.H., Gao L., Wang J.M., Bian X.W. Isolation and characterization of cancer stem cells from a human glioblastoma cell line U87. Cancer Lett. 2008, 265:124-134.
39. Zeisberger S.M., Odermatt B., Marty C., Zehnder-Fjallman A.H., Ballmer-Hofer K., Schwendener R.A. Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach. Br. J. Cancer 2006, 95:272-281.
40. Zeppernick F., Ahmadi R., Campos B., Dictus C., Helmke B.M., Becker N., Lichter P., Unterberg A., Radlwimmer B., Herold-Mende C.C. Stem cell marker CD133 affects clinical outcome in glioma patients. Clin. Cancer Res. 2008, 14:123-129.